ArticleInternational journal of women's health2012

Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation.

Plamen Kinov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.